Global aflatoxicosis treatment market is anticipated to witness substantial growth by 2028.
 

Industry Snapshot:
 

• Surging prevalence of foodborne diseases is the main factor driving the market growth during the review period.
• Increasing awareness of aflatoxins is stimulating the industry outlook.
• The favorable initiatives from government authorities as well as rising food trade in developing countries have augmented the demand for the service across the globe.

• A lack of infrastructure and resources in developing regions impedes the growth of global aflatoxicosis treatment market over the forecast period of 2022-2028.

Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/5490037/  

Segmental Overview:

Treatment	Immunosuppressants
	Antihistamines
	Antibiotics
	Oxygen Therapy
	Blood Transfusion
	Others
Regional Bifurcation	Europe
	Latin America
	Asia Pacific
	North America

 

Predictions Corner:
 

• North America market is expected to expand significantly in the ensuing years, owing to the growing concern over food safety & contamination and the presence of leading players in the region.
• Asia-Pacific aflatoxicosis treatment market is anticipated to exhibit the highest growth rate over the forthcoming years, ascribed to the growing incidences of post-harvest crop loss and funding activities from government authorities in the region.

Explainer – All you need to know

For the unversed, aflatoxicosis is a disease caused by aflatoxin consumption, which is found in both humans and animals. Aflatoxins are a type of toxin produced by a fungus found on several agricultural products such as maize, peanuts, cottonseed, and tree nuts, as well as it causes a variety of adverse effects, including nausea, vomiting, abdominal discomfort, and seizures. Aspergillus flavus and Aspergillus parasiticus, which live in warm and humid environments, are the major fungus that creates aflatoxins.

Zydus Lifesciences Limited, Sanofi S.A., Pfizer Inc., Merck & Co. Inc., Johnson & Johnson Services Inc., GlaxoSmithKline plc., F. Hoffmann-La Roche AG, AstraZeneca plc, AbbVie Inc., and Abbott Laboratories are the leading companies operating in global aflatoxicosis treatment industry.

Concluding lines:

Market researchers gather, present, and investigate information to precisely signify the range of features of a business sphere. MarketStudyReport now offers premium access to a report titled ‘Global Aflatoxicosis Treatment Market Size study, By Treatment (Aflatoxicosis Treatment by Blood Transfusion, Aflatoxicosis Treatment by Oxygen Therapy, Aflatoxicosis Treatment by Antibiotics, Aflatoxicosis Treatment by Antihistamines, Aflatoxicosis Treatment by Immunosuppressants, Aflatoxicosis Treatment by Others), and Regional Forecasts 2022-2028’, which analyzes the shifting market patterns, potential business avenues, and hardships present around this vertical. The report offers all the information expected by associations working in this field and was made after a wide and careful assessment to ensure favorable returns and high profitability.